Home
>
US Stocks
>
Acelrx Pharmaceuticals Inc
Acelrx Pharmaceuticals Inc
ACRX

Acelrx Pharmaceuticals Inc (ACRX)

$0.91.1%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
$0.92
Today Low/High
$0.9 / $0.92
52 Week Low/High
$0.75 / $2.94
Market Cap
$108.81M

Company Details

AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. AcelRx's proprietary, non-invasive sublingual formulation technology delivers sufentanil with consistent pharmacokinetic profiles. AcelRx has one approved product in the U.S., DSUVIA® (sufentanil sublingual tablet, 30 mcg), known as DZUVEO™ in Europe, indicated for the management of acute pain severe enough to require an opioid analgesic for adult patients in certified medically supervised healthcare settings, and one product candidate, Zalviso® (sufentanil sublingual tablet system, SST system, 15 mcg), an investigational product in the U.S., is being developed as an innovatively designed patient-controlled analgesia (PCA) system for reduction of moderate-to-severe acute pain in medically supervised settings. DZUVEO and Zalviso are both approved products in Europe.
Organisation
Acelrx Pharmaceuticals Inc
Headquaters
Redwood City, California, US
Employees
54
Industry
Health Technology
CEO
Vincent Angotti

Discover more

Frequently Asked Questions

What is Acelrx Pharmaceuticals Inc (ACRX) share price today?

Can Indians buy Acelrx Pharmaceuticals Inc (ACRX) shares?

How can I buy Acelrx Pharmaceuticals Inc (ACRX) shares from India?

Can Fractional shares of Acelrx Pharmaceuticals Inc (ACRX) be purchased?

What are the documents required to start investing in Acelrx Pharmaceuticals Inc (ACRX) stocks?

We are a SEBI registered investement advisor